Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A new drug for people with a particular form of cystic fibrosis, available in England, must also be prescribed in Scotland, a charity has said.
NHS patients in England will be able to access Kalydeco, also known as ivacaftor, from 1 January.
The Cystic Fibrosis Trust said not funding the drug in Scotland would cause "dismay and heartache".
The trust said it was appalled that people in Scotland were denied a potentially life-changing treatment.
http://www.bbc.co.uk/news/uk-scotland-20870161
NHS patients in England will be able to access Kalydeco, also known as ivacaftor, from 1 January.
The Cystic Fibrosis Trust said not funding the drug in Scotland would cause "dismay and heartache".
The trust said it was appalled that people in Scotland were denied a potentially life-changing treatment.
http://www.bbc.co.uk/news/uk-scotland-20870161